Authored by Zipher Medical Affairs, now part of Lumanity
Insights provide the ability to gain a clear, deep, and sometimes unexpected understanding of a complicated problem or situation. In the pharmaceutical arena, insights are external trends that are actionable and have the potential to alter medical strategy. To gain a competitive advantage, pharmaceutical companies utilize medical affairs organizations to analyze what is driving the therapeutic landscape and clinical decision making. This understanding is developed through external data collection through 1:1 meetings, ad boards, and congress engagement. However, these data are often cumbersome and require analyses to separate the noise from actionable insights. To effectively align medical strategy with factors driving the competitive landscape, companies require a process that smoothly integrates insight collection, analysis, and application to gain a competitive edge.